Form 8.3 - AGI Therapeutics (0221W)
January 23 2012 - 9:49AM
UK Regulatory
TIDMAGI
RNS Number : 0221W
Credit Agricole CheuvReux Intl Ltd
23 January 2012
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS
IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
=================================================================
Name of person dealing CREDIT AGRICOLE CHEUVREUX
(Note 1) INTERNATIONAL LIMITED
============================= ==================================
Company dealt in AGI Therapeutics
============================= ==================================
Class of relevant IE00B0YT0Q82
security to which
the dealings being
disclosed relate
(Note 2)
============================= ==================================
Date of dealing 18/01/2012
============================= ==================================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions
(following dealing) in the class of
relevant security dealt in (Note 3)
=================================================================
Long Short
============================= =============== =================
Number (%) Number (%)
============================= =============== =================
(1) Relevant securities 675,000 (1.00%)
============================= =============== =================
(2) Derivatives
(other than options)
- CFD
============================= =============== =================
(3) Options and
agreements to purchase/sell
============================= =============== =================
Total 675,000 (1.00%)
============================= =============== =================
(b) Interests and short positions
in relevant securities of the company,
other than the class dealt in (Note
3)
=================================================================
Class of relevant Long Short
security:
============================= =============== =================
Number (%) Number (%)
============================= =============== =================
(1) Relevant securities
============================= =============== =================
(2) Derivatives
(other than options)
============================= =============== =================
(3) Options and
agreements to purchase/sell
============================= =============== =================
Total
============================= =============== =================
1 February 2009
3.
DEALINGS
(Note
4)
(a)
Purchases
and
sales
===========================================================================================================
Purchase/sale Number of relevant Price per
securities unit (Note
5)
================== ================================================= ====================================
Purchase 300,000 0.07 GBP
================== ================================================= ====================================
(b)
Derivatives
transactions
(other
than
options
transactions)
===========================================================================================================
Product
name, Nature of Number of relevant Price
e.g. CFD transaction securities per unit
(Note 6) (Note 7) (Note
5)
================ ==================== =========================================== ======================
CFD Short 300,000 0.07
GBP
================ ==================== =========================================== ======================
(c)
Options
transactions
in
respect
of
existing
relevant
securities
(i)
Writing,
selling,
purchasing
or
varying
===========================================================================================================
Product Writing, Number Exercise Type, Expiry Option
name, selling, of securities price e.g. date money
e.g. purchasing, to which American, paid/received
call varying the option European per
option etc. relates etc. unit
(Note (Note
7) 5)
============== ==================== ================ =========== ============ ======== ==============
(ii)
Exercising
===========================================================================================================
Product name, Number of securities Exercise
e.g. call price per
option unit (Note
5)
================== ================================================= ====================================
(d)
Other
dealings
(including
transactions
in
respect
of
new
securities)
(Note
4)
===========================================================================================================
Nature of Details Price per
transaction unit
(Note 8) (if applicable)
(Note 5)
================== ================================================= ====================================
1
February
2009
4. OTHER INFORMATION
Agreements, arrangements or understandings
relating to options or derivatives
=================================================
Full details of any agreement, arrangement
or understanding between the person
disclosing and any other person relating
to the voting rights of any relevant
securities under any option referred
to on this form or relating to the
voting rights or future acquisition
or disposal of any relevant securities
to which any derivative referred to
on this form is referenced. If none,
this should be stated.
=================================================
Is a Supplemental Form 8 attached?
(Note 9) YES/NO
=================================================
Date of disclosure 23/01/2012
============================ ===================
Contact name Olanike Bola-Lateef
============================ ===================
Telephone number 0207 214 6519
============================ ===================
If a connected EFM,
name of offeree/offeror
with which connected
============================ ===================
If a connected EFM,
state nature of connection
(Note 10)
============================ ===================
1 February 2009
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETDMGZMDFKGZZM
AGI (LSE:AGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
AGI (LSE:AGI)
Historical Stock Chart
From Apr 2023 to Apr 2024
